Fig. 2. Sex difference of the marker genes in predicting the clinical outcomes of liver cancer patients. Group 1 (g1), liver cancer patients with high expression of CTNNB1, IL6, and RHOA and low expression of GLIPR1; Group 2 (g2), the other patients. (A) In all liver cancer patients; (B) In female and (C) male liver cancer patients.
© Biomolecules & Therapeutics
